---
figid: PMC4624607__nihms722744f3
figlink: /pmc/articles/PMC4624607/figure/F3/
number: FIGURE 3
caption: Schematic illustration of distinct signaling pathways induced by rhTum and
  rhEndo. rhTum binds to αvβ3 integrin, whereas rhEndo binds to α5β1. Both rhEndo
  and rhTum inhibit phosphorylation of FAK (yellow). Downstream of FAK, rhTum inhibits
  PI3-K/Akt/mTor/4EBP1 pathway, resulting in inhibition of endothelial protein synthesis
  and proliferation. MAP kinase pathways are not affected by rhTum. In contrast, inhibition
  of FAK activation by rhEndo binding to α5β1 integrin leads to inhibition of ERK1/p38
  MAP kinase pathways with no effect on PI3-K/Akt/mTOR/4EBP1 pathways, resulting in
  inhibition of endothelial cell migration. [Adapted from Sudhaker et al. []]
pmcid: PMC4624607
papertitle: Endostatin’s Emerging Roles in Angiogenesis, Lymphangiogenesis, Disease,
  and Clinical Applications.
reftext: Amit Walia, et al. Biochim Biophys Acta. ;1850(12):2422-2438.
pmc_ranked_result_index: '6633'
pathway_score: 0.9388699
filename: nihms722744f3.jpg
figtitle: Distinct signaling pathways induced by rhTum and rhEndo
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4624607__nihms722744f3.html
  '@type': Dataset
  description: Schematic illustration of distinct signaling pathways induced by rhTum
    and rhEndo. rhTum binds to αvβ3 integrin, whereas rhEndo binds to α5β1. Both rhEndo
    and rhTum inhibit phosphorylation of FAK (yellow). Downstream of FAK, rhTum inhibits
    PI3-K/Akt/mTor/4EBP1 pathway, resulting in inhibition of endothelial protein synthesis
    and proliferation. MAP kinase pathways are not affected by rhTum. In contrast,
    inhibition of FAK activation by rhEndo binding to α5β1 integrin leads to inhibition
    of ERK1/p38 MAP kinase pathways with no effect on PI3-K/Akt/mTOR/4EBP1 pathways,
    resulting in inhibition of endothelial cell migration. [Adapted from Sudhaker
    et al. []]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - PIK3CG
  - PIK3R4
  - PIK3R3
  - PIK3CD
  - RAF1
  - PIK3CA
  - PIK3CB
  - PTK2
  - KRAS
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAP3K1
  - AKT2
  - AKT3
  - ARAF
  - HRAS
  - MTOR
  - MAPK14
  - PIK3R5
  - NRAS
  - EIF4EBP1
  - MAPK12
  - PIK3R6
  - MAPK13
  - MAPK11
  - BRAF
  - Endostatin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEKK
  symbol: MEKK
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals:
- word: Endostatin
  source: MESH
  identifier: D043169
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
